Review of Pharmacology - 9E (2015)

Review of Pharmacology
39. Ans. (a) 5%iodine & 10% KI (Ref: KDT 7/e p255)
40. Ans. (c) Actrapid (Ref: KDT 7/e p264-265)
• Actrapid (regular insulin) and monotard (Lente-insulin) are unmodified insulins with same amino acid squence as
natural insulin
• Lispro, aspart, glulisine and glargine are insulin analogues in which slightly different amino acid sequence is present
to modify pharmacokinetics.
41. Ans. (b) Ritodrine (Ref: KDT 7/e p136)
42. Ans. (b) Atosiban (Ref: KDT 7/e p333)
43. Ans. (c) Post partum hemorrhage (Ref: KDT 7/e p320)
44. Ans. (d) Etidronate (Ref: KDT 7/e p345)
45. Ans. (a) 5-alpha reductase (Ref: KDT 7/e p302)
46. Ans. (b) Hyperkalemia (Ref: KDT 7/e p293)
47. Ans. (a) Suppression of inflammation and improvement in functional capacity (Ref: KDT 7/e p291)
48. Ans. (c) Finasteride (Ref: KDT 7/e p302)
49. Ans. (d) Active liver disease (Ref: KDT 7/e p326)
50. Ans. (c) Cortical collecting duct (Ref: KDT 7/e p283-284)
51. Ans. (b) Prednisolone (Ref: KDT 7/e p293)
• Etidronate and phenytoin cause osteomalacia whereas calcitriol is used in treatment of osteoporosis.
Endocrinology
52. Ans. (c) Level of thyroid stimulating hormone (Ref: KDT 7/e p248)
53. Ans. (c) Metformin (Ref: KDT 7/e p276)
54. Ans. (c) Oral I 131 (Ref: CMDT 2014/ p1078)
55. Ans. (d) Irregular menstrual bleeding and prolonged anovulation (Ref: KDT 7/e p323)
56. Ans. (b) Ovarian cancer (Ref: KDT 7/e p326)
57. Ans. (b) Cortisone for Cushing’s syndrome (Ref: KDT 7/e p291-293)
58. Ans. (a) Cerebral stroke (Ref: KDT 7/e p325)
59. Ans. (b) Propanolol (Ref: KDT 7/e p256)
60. Ans. (c) Anti-progestin (Ref: KDT 7/e p319)
61. Ans. (b) Stimulating the beta islet cells of pancreas to release insulin (Ref: KDT 7/e p270-271)
62. Ans. (d) Relaxin (Ref: KDT 7/e p306)
63. Ans. (b) Prolactin deficiency (Ref: KDT 7/e p239)
64. Ans. (c) To suspect adrenocortical insufficiency and start IV steroids (Ref: KDT 7/e p290)
65. Ans. (a) Metformin (Ref: KDT 7/e p276)
66. Ans. (a) Metformin (Ref: KDT 7/e p276)
67. Ans. (b) Intravenous fluids (saline) (Ref: CMDT 2014 p1190)
68. Ans. (a) Betamethasone valerate (Ref: KDT 7/e p895)
69. Ans. (c) Vitamin K (Ref: CMDT 2014 p712)
308
https://kat.cr/user/Blink99/